Please try another search
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. Its products include thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems, aortic dissection, percutaneous transluminal angioplasty, and balloon catheters, as well as accessories, such as balloon inflation catheter. Shanghai MicroPort Endovascular MedTech Co., Ltd. was founded in 2012 and is based in Shanghai, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Qing Zhu | 42 | 2018 | GM & Director |
Baolin Liu | 56 | 2018 | Independent Director |
Rong Fu | 60 | 2018 | Independent Director |
Xiaojie Ye | 38 | 2022 | Independent Director |
Jonathan H. Chen | 49 | 2023 | Chairman |
Chao Guo | 37 | 2023 | Supervisor |
Linlin Cai | 44 | 2018 | Employee Representative Supervisor |
Min Liang | 38 | 2023 | Chairman of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review